Forum : Stock: [KOOL]: Cesca Therapeutics | I3investor

Stock: [KOOL]: Cesca Therapeutics

Be the first to like this.

2 comment(s). Last comment by optimusprime 2014-01-23 12:54

2 posts

Posted by francis68 > 2014-01-22 12:04 | Report Abuse

KOOL stop 4.09

optimusprime

1 posts

Posted by optimusprime > 2014-01-23 12:54 | Report Abuse

1

Post a Comment

Market Buzz

Apps

Send individual or group chats with anyone on i3investor

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

Online learning and teaching marketplace

Top Articles

1

CryptoNews

CryptoNews of the Week

2

NordFX Weekly Forecast

Forex and Cryptocurrencies Forecast for September 25 - 29, 2023

Hot Stocks Today >

1

Monroe Capital Corporation

1000

2

Freeport-McMoRan Inc.

727

3

CenterPoint Energy, Inc.

545

4

Macy's, Inc.

454

5

Huron Consulting Group Inc.

363

6

Neonode Inc.

363

7

Microsoft Corporation

363

8

Alibaba Group Holding Limited

345

9

Comstock Resources, Inc.

272

10

Continental Resources, Inc.

272

Daily Stocks

0.218

+0.132

204,845,734

8.18

-0.17

184,885,916

0.123

-0.017

174,563,765

0.075

-0.028

174,510,874

0.452

+0.152

166,986,684

20.48

-0.47

139,957,529

3.51

-2.68

134,385,469

1.42

-0.31

133,259,138

53.70

+0.35

132,702,677

35.54

+0.84

132,031,433

More active Stocks

6,061.92

+120.92

16,692

1,838.73

+32.65

289,323

3,104.83

+22.17

265,606

1,891.46

+21.06

53,038

1,118.24

+20.46

134,564

63.24

+20.01

603,885

124.95

+19.77

6,975,345

2,559.48

+18.58

81,580

57.22

+18.22

1,071

1,274.14

+17.62

347,189

More gainer Stocks

541,105.00

-1,390.00

7,017

106.04

-161.79

33,202,552

1,342.64

-41.09

579,020

1,406.70

-37.32

36,980

1,502.99

-23.23

18,862

194.92

-21.63

22,838,044

549.53

-21.02

1,038,743

913.63

-20.01

111,410

211.22

-19.59

9,178,312

333.62

-18.04

1,744,187

More loser Stocks

Top Brokers >

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....